These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14728991)

  • 1. The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria.
    Harding CO; Neff M; Wild K; Jones K; Elzaouk L; Thöny B; Milstien S
    Mol Genet Metab; 2004 Jan; 81(1):52-7. PubMed ID: 14728991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system.
    Ding Z; Harding CO; Rebuffat A; Elzaouk L; Wolff JA; Thöny B
    Mol Ther; 2008 Apr; 16(4):673-81. PubMed ID: 18362925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pah(enu2) mice.
    Harding CO; Neff M; Jones K; Wild K; Wolff JA
    J Gene Med; 2003 Nov; 5(11):984-93. PubMed ID: 14601136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle.
    Harding CO; Wild K; Chang D; Messing A; Wolff JA
    Gene Ther; 1998 May; 5(5):677-83. PubMed ID: 9797873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening and diagnosis of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency with tetrahydrobiopterin loading test].
    Zhang ZX; Ye J; Qiu WJ; Han LS; Gu XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):335-9. PubMed ID: 15924746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene.
    Shintaku H; Kure S; Ohura T; Okano Y; Ohwada M; Sugiyama N; Sakura N; Yoshida I; Yoshino M; Matsubara Y; Suzuki K; Aoki K; Kitagawa T
    Pediatr Res; 2004 Mar; 55(3):425-30. PubMed ID: 14681498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
    Dobrowolski SF; Heintz C; Miller T; Ellingson C; Ellingson C; Ozer I; Gökçay G; Baykal T; Thöny B; Demirkol M; Blau N
    Mol Genet Metab; 2011 Feb; 102(2):116-21. PubMed ID: 21147011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypothesis on the biochemical mechanism of BH(4)-responsiveness in phenylalanine hydroxylase deficiency.
    Steinfeld R; Kohlschütter A; Ullrich K; Lukacs Z
    Amino Acids; 2003 Jul; 25(1):63-8. PubMed ID: 12836060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
    Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art.
    Spaapen LJ; Rubio-Gozalbo ME
    Mol Genet Metab; 2003 Feb; 78(2):93-9. PubMed ID: 12618080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of BH4 -responsive hyperphenylalaninemia--as it occurs in the ENU1/2 genetic mouse model.
    Sarkissian CN; Ying M; Scherer T; Thöny B; Martinez A
    Hum Mutat; 2012 Oct; 33(10):1464-73. PubMed ID: 22644647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tetrahydrobiopterin and phenylalanine on in vivo human phenylalanine hydroxylase by phenylalanine breath test.
    Okano Y; Takatori K; Kudo S; Sakaguchi T; Asada M; Kajiwara M; Yamano T
    Mol Genet Metab; 2007 Dec; 92(4):308-14. PubMed ID: 17884650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic basis of sexual dimorphism in PKU mice after genome-targeted PAH gene therapy.
    Chen L; Thung SN; Woo SL
    Mol Ther; 2007 Jun; 15(6):1079-85. PubMed ID: 17406346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response.
    Staudigl M; Gersting SW; Danecka MK; Messing DD; Woidy M; Pinkas D; Kemter KF; Blau N; Muntau AC
    Hum Mol Genet; 2011 Jul; 20(13):2628-41. PubMed ID: 21527427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
    Dobrowolski SF; Borski K; Ellingson CC; Koch R; Levy HL; Naylor EW
    J Hum Genet; 2009 Jun; 54(6):335-9. PubMed ID: 19444284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of phenylalanine hydroxylase activity by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Heintz C; Troxler H; Martinez A; Thöny B; Blau N
    Mol Genet Metab; 2012 Apr; 105(4):559-65. PubMed ID: 22300847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Zurflüh MR; Zschocke J; Lindner M; Feillet F; Chery C; Burlina A; Stevens RC; Thöny B; Blau N
    Hum Mutat; 2008 Jan; 29(1):167-75. PubMed ID: 17935162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype.
    Lindner M; Haas D; Mayatepek E; Zschocke J; Burgard P
    Mol Genet Metab; 2001 May; 73(1):104-6. PubMed ID: 11350190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocytes from wild-type or heterozygous donors are equally effective in achieving successful therapeutic liver repopulation in murine phenylketonuria (PKU).
    Hamman KJ; Winn SR; Harding CO
    Mol Genet Metab; 2011 Nov; 104(3):235-40. PubMed ID: 21917493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.